How dangerous is omicron and how effective are vaccinations?

Abstract

The sharp increase in the number of new COVID-19 cases in late 2021 and early 2022, which is associated with the spread of a new strain of coronavirus - omicron - is of great concern and makes it necessary to make at least approximate forecasts for the pandemic dynamics of the epidemic. As this rapid growth occurs even in countries with high levels of vaccinations, the question arises as to their effectiveness. The smoothed daily number of new cases and deaths per capita and the ratio of these characteristics were used to reveal the appearance of new coronavirus strains and to estimate the effectiveness of quarantine, testing and vaccination. The third year of the pandemic allowed us to compare the pandemic dynamics in the period from September 2020 to January 2021 with the same period one year later for Ukraine, EU, the UK, USA, India, Brazil, South Africa, Argentina, Australia, and in the whole world. Record numbers of new cases registered in late 2021 and early 2022 once again proved that existing vaccines cannot prevent new infections, and vaccinated people can spread the infection as intensively as non-vaccinated ones. Fortunately, the daily number of new cases already diminishes in EU, the UK, USA, South Africa, and Australia. In late January - early February 2022,the maximum averaged numbers of new cases are expected in Brazil, India, EU, and worldwide. Omicron waves can increase the numbers of deaths per capita, but in highly vaccinated countries, the deaths per case ratio significantly decreases.

A Pest Analysis of Dynamic Leadership During a Crisis in the ASEAN Region

“…The objective of limiting outside travellers constantly changed over the period from 2019 to 2022. The variation in the new coronavirus strain, Omicron, was a great concern to society (Nesteruk & Rodionov, 2022). The leaders were always aware of the risks and undertake mobility restrictions based on the capability of the respective countries.…”

New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)

“…Исследования в Великобритании, Шотландии и Дании выявили снижение эффективности вакцины против инфекции Омикрон, при этом доказана более высокая эффективность вакцинации при использовании бустерных доз [36,42,43].…”